素印记 聚甲基多巴) 用于生物标志物检测和疾病治疗
Xiaofeng Sun1, Tianqing Hu1, Yuexia Bai2
1Qilu University of Technology (Shandong Academy of Sciences), School of Chemistry and Chemical Engineering, Jinan, 250353, PR China.
Biosensors & bioelectronics
|March 19, 2024
概括
这项研究引入了用于高血压的双功能素印记聚合物 (RMIP). 这些工程纳米结构使敏感的生物标志物检测和有效的体内疾病治疗,没有观察到的毒性.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 聚合物化学 聚合物化学
背景情况:
- 传统的分子印记聚合物 (MIP) 依赖于3D空腔进行模板识别.
- 功能性单体在MIP中的作用可以扩展到简单的识别位形成之外.
研究的目的:
- 开发双重功能氨酸印记聚合物 (RMIPs),整合药物和生物标志物功能.
- 通过计算设计和受控聚合来增强灵敏度和结合亲和力.
- 探索生物标志物检测和高血压治疗的体内应用.
主要方法:
- 密度功能理论 (DFT) 计算用于识别站点的微结构设计.
- 控制的聚合技术来调节RMIP薄膜的特性.
- 在小鼠体内研究以评估治疗疗效和毒性.
主要成果:
- 基于RMIP的生物传感器实现了高度敏感的雷宁生物标志物检测 (LODs降至1.31 × 10−6 ng mL−1).
- 在体内治疗表明小鼠的血压显著下降.
- 病理学分析显示没有急性或长期毒性.
结论:
- 工程RMIP为高血压管理提供了一个有前途的双功能平台.
- 开发的纳米结构显示出在诊断和治疗中临床翻译的潜力.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
621
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
621
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K


